Post by
Red~One on Mar 30, 2022 9:48am
RE:N.O. in the news, No Clas
Next time do your own DD.
"...best-in-class technology that improves the clinical care of patients requiring inhaled nitric oxide therapy. GENOSYL has gained significant market traction with adoption by some of the top hospitals in the US."
Dec 21, 2021, 09:40 ET
https://www.prnewswire.com/news-releases/vero-biotech-receives-funding-from-mvm-partners-to-accelerate-growth-301449098.html
Comment by
PTBailey on Mar 30, 2022 10:38am
This post has been removed in accordance with Community Policy